{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:04:00Z","timestamp":1792112640933,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA057712"],"award-info":[{"award-number":["T32 CA057712"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11764-021-01161-0","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T06:02:49Z","timestamp":1641621769000},"page":"1149-1160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors"],"prefix":"10.1007","volume":"17","author":[{"given":"Andrea C.","family":"Betts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin C.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Aubree","family":"Shay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijal A.","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Markham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlyn","family":"Allicock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"1161_CR1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1634\/theoncologist.2014-0265","volume":"20","author":"SJ Nass","year":"2015","unstructured":"Nass SJ, Beaupin LK, Demark-Wahnefried W, et al. Identifying and addressing the needs of adolescents and young adults with cancer: Summary of an Institute of Medicine workshop. Oncologist. 2015;20:186\u201395.","journal-title":"Oncologist"},{"key":"1161_CR2","unstructured":"Adolescents and Young Adults with Cancer. National Cancer Institute. Updated September 24, 2020. https:\/\/www.cancer.gov\/types\/aya. Accessed 14 Nov 2018"},{"key":"1161_CR3","unstructured":"Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. https:\/\/seer.cancer.gov\/csr\/1975_2015\/. Published April 1, 2018. Updated September 10, 2018. Accessed 14 Nov 2018"},{"key":"1161_CR4","volume-title":"Closing the gap: research and care imperatives for adolescents and young adults with cancer","author":"K Albritton","year":"2006","unstructured":"Albritton K, Caligiuri M, Anderson B, Nichols C, Ulman D. Closing the gap: research and care imperatives for adolescents and young adults with cancer. Bethesda, MD: National Institutes of Health, National Cancer Institute, LIVESTRONG Young Adult Alliance; 2006."},{"key":"1161_CR5","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/1055-9965.EPI-15-0401","volume":"24","author":"XC Wu","year":"2015","unstructured":"Wu XC, Prasad PK, Landry I, et al. Impact of the AYA HOPE comorbidity index on assessing health care service needs and health status among adolescents and young adults with cancer. Cancer Epidemiol Biomarkers Prev. 2015;24:1844\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1161_CR6","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1002\/cncr.27445","volume":"118","author":"E Tai","year":"2012","unstructured":"Tai E, Buchanan N, Townsend J, Fairley T, Moore A, Richardson LC. Health status of adolescent and young adult cancer survivors. Cancer. 2012;118:4884\u201391.","journal-title":"Cancer"},{"key":"1161_CR7","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/cncr.31389","volume":"124","author":"CC Murphy","year":"2018","unstructured":"Murphy CC, Fullington HM, Alvarez CA, et al. Polypharmacy and patterns of prescription medication use among cancer survivors. Cancer. 2018;124:2850\u20137.","journal-title":"Cancer"},{"key":"1161_CR8","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1634\/theoncologist.2019-0406","volume":"25","author":"MR Mohamed","year":"2020","unstructured":"Mohamed MR, Ramsdale E, Loh KP, et al. Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: A systematic review and meta-analysis. Oncologist. 2020;25:e94.","journal-title":"Oncologist."},{"key":"1161_CR9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse outcomes of polypharmacy in older people: Systematic review of reviews. J Am Med Dir Assoc. 2020;21:181\u20137.","journal-title":"J Am Med Dir Assoc"},{"key":"1161_CR10","doi-asserted-by":"publisher","unstructured":"Nieder C, Manns\u0103ker B, Pawinski A, Haukland E. Polypharmacy in older patients \u2265 70 years receiving palliative radiotherapy. Anticancer res. 2017;37:795\u2013799. https:\/\/doi.org\/10.21873\/anticanres.11379","DOI":"10.21873\/anticanres.11379"},{"key":"1161_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5455\/msm.2016.28.129-132","volume":"28","author":"E Zelko","year":"2016","unstructured":"Zelko E, Klemenc-Ketis Z, Tusek-Bunc K. Medication adherence in elderly with polypharmacy living at home: A systematic review of existing studies. Mater Sociomed. 2016;28:129\u201332.","journal-title":"Mater Sociomed"},{"key":"1161_CR12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57\u201365.","journal-title":"Expert Opin Drug Saf"},{"key":"1161_CR13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/jayao.2018.0160","volume":"8","author":"ME McGrady","year":"2019","unstructured":"McGrady ME, Pai ALH. A systematic review of rates, outcomes, and predictors of Medication non-adherence among adolescents and young adults with cancer. J Adolesc Young Adult Oncol. 2019;8:485\u201394.","journal-title":"J Adolesc Young Adult Oncol"},{"key":"1161_CR14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1377\/hlthaff.2013.1425","volume":"33","author":"GP Guy Jr","year":"2014","unstructured":"Guy GP Jr, Yabroff KR, Ekwueme DU, et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Aff. 2014;33:1024\u201331.","journal-title":"Health Aff"},{"key":"1161_CR15","doi-asserted-by":"publisher","unstructured":"Hsu CD, Nichols HB, Lund JL. Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003\u20132014. J Cancer Surviv. 2021.\u00a0https:\/\/doi.org\/10.1007\/s11764-11021-01059-x.","DOI":"10.1007\/s11764-11021-01059-x"},{"key":"1161_CR16","doi-asserted-by":"publisher","unstructured":"Blewett LA, Rivera Drew JA, Griffin R, Williams KCW. IPUMS health surveys: Medical expenditure panel survey, version 1.1. Minneapolis, MN: IPUMS, 2019.\u00a0https:\/\/doi.org\/10.18128\/D071.V1.1.","DOI":"10.18128\/D071.V1.1"},{"key":"1161_CR17","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/MLR.0b013e3181a23e3a","volume":"47","author":"JW Cohen","year":"2009","unstructured":"Cohen JW, Cohen SB, Banthin JS. The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice. Med Care. 2009;47:S44-50.","journal-title":"Med Care"},{"key":"1161_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"EA Stuart","year":"2010","unstructured":"Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25:1\u201321.","journal-title":"Stat Sci"},{"key":"1161_CR19","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","volume":"41","author":"K Kroenke","year":"2003","unstructured":"Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284\u201392.","journal-title":"Med Care"},{"key":"1161_CR20","doi-asserted-by":"crossref","first-page":"9074","DOI":"10.1200\/jco.2010.28.15_suppl.9074","volume":"28","author":"T Jorgensen","year":"2010","unstructured":"Jorgensen T, Hallas J, Herrstedt J. Polypharmacy in elderly cancer patients. J Clin Oncol. 2010;28:9074\u20139074.","journal-title":"J Clin Oncol"},{"key":"1161_CR21","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00520-015-2970-8","volume":"24","author":"JP Turner","year":"2016","unstructured":"Turner JP, Jamsen KM, Shakib S, Singhal N, Prowse R, Bell JS. Polypharmacy cut-points in older people with cancer: how many medications are too many? Support Care Cancer. 2016;24:1831\u201340.","journal-title":"Support Care Cancer"},{"key":"1161_CR22","unstructured":"Appendix 3: Multum lexicon therapeutic classification scheme. In National health and nutrition examination survey, 1988-2020 Data documentation, codebook, and frequencies. Centers for Disease Control and Prevention. August 2007. Updated September 1, 2021. https:\/\/wwwn.cdc.gov\/Nchs\/Nhanes\/1999-2000\/RXQ_DRUG.htm#Appendix_3:_Multum_Lexicon_Therapeutic_Classification_Scheme_. Accessed 1 May 2020."},{"key":"1161_CR23","unstructured":"SAS [Computer Software]. Version 9.4. Cary, NC: SAS Institute, 2014."},{"key":"1161_CR24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/djy229","volume":"111","author":"SH Armenian","year":"2019","unstructured":"Armenian SH, Gibson CJ, Rockne RC, Ness KK. Premature aging in young cancer survivors. J Natl Cancer Inst. 2019;111:226\u201332.","journal-title":"J Natl Cancer Inst"},{"key":"1161_CR25","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1002\/cncr.28262","volume":"119","author":"EE Kent","year":"2013","unstructured":"Kent EE, Forsythe LP, Yabroff KR, et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013;119:3710\u20137.","journal-title":"Cancer"},{"key":"1161_CR26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11764-012-0219-9","volume":"6","author":"TH Keegan","year":"2012","unstructured":"Keegan TH, Lichtensztajn DY, Kato I, et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv. 2012;6:239\u201350.","journal-title":"J Cancer Surviv"},{"key":"1161_CR27","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1002\/cncr.27512","volume":"118","author":"KM Bellizzi","year":"2012","unstructured":"Bellizzi KM, Smith A, Schmidt S, et al. Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer. 2012;118:5155\u201362.","journal-title":"Cancer"},{"key":"1161_CR28","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/cncr.30648","volume":"123","author":"S Kaul","year":"2017","unstructured":"Kaul S, Avila JC, Mehta HB, Rodriguez AM, Kuo YF, Kirchhoff AC. Cost-related medication nonadherence among adolescent and young adult cancer survivors. Cancer. 2017;123:2726\u201334.","journal-title":"Cancer"},{"key":"1161_CR29","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1200\/JCO.2011.36.2954","volume":"29","author":"HM Parsons","year":"2011","unstructured":"Parsons HM, Harlan LC, Seibel NL, Stevens JL, Keegan TH. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? J Clin Oncol. 2011;29:4045\u201353.","journal-title":"J Clin Oncol"},{"key":"1161_CR30","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1200\/JCO.20.00722","volume":"38","author":"C Chao","year":"2020","unstructured":"Chao C, Bhatia S, Xu L, et al. Chronic comorbidities among survivors of adolescent and young adult cancer. J Clin Oncol. 2020;38:3161\u201374.","journal-title":"J Clin Oncol"},{"key":"1161_CR31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","volume":"65","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989\u201395.","journal-title":"J Clin Epidemiol"},{"key":"1161_CR32","doi-asserted-by":"publisher","unstructured":"Pamoukdjian F, Aparicio T, Zelek L, Boubaya M, Caillet P, Fran\u00e7ois, V, de Decker L, L\u00e9vy V, Sebbane G, Paillaud E. Impaired mobility, depressed mood, cognitive impairment and polypharmacy are independently associated with disability in older cancer outpatients: the prospective Physical Frailty in Elderly Cancer patients (PF-EC) cohort study. J Geriatr Oncol. 8: 190-195. https:\/\/doi.org\/10.1016\/j.jgo.2017.02.003.","DOI":"10.1016\/j.jgo.2017.02.003"},{"key":"1161_CR33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fonc.2013.00075","volume":"3","author":"AW Smith","year":"2013","unstructured":"Smith AW, Parsons HM, Kent EE, et al. Unmet support service needs and health-related quality of life among adolescents and young adults with cancer. Front Oncol. 2013;3:75.","journal-title":"Front Oncol"},{"key":"1161_CR34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejon.2010.05.011","volume":"14","author":"C Xiao","year":"2010","unstructured":"Xiao C. The state of science in the study of cancer symptom clusters. Eur J Oncol Nurs. 2010;14:417\u201334.","journal-title":"Eur J Oncol Nurs"},{"key":"1161_CR35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1049909110364048","volume":"27","author":"J Kirkova","year":"2010","unstructured":"Kirkova J, Walsh D, Aktas A, Davis MP. Cancer symptom clusters: Old concept but new data. Am J Hosp Palliat Care. 2010;27:282\u20138.","journal-title":"Am J Hosp Palliat Care"},{"key":"1161_CR36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00482-016-0125-6","volume":"31","author":"K Geue","year":"2017","unstructured":"Geue K, Schmidt R, Sender A, Friedrich M. Pain experiences and life satisfaction of young adult cancer patients. Schmerz. 2017;31:23\u201330.","journal-title":"Schmerz"},{"key":"1161_CR37","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/jpepsy\/jsu072","volume":"39","author":"JH Ehrentraut","year":"2014","unstructured":"Ehrentraut JH, Kern KD, Long SA, An AQ, Faughnan LG, Anghelescu DL. Opioid misuse behaviors in adolescents and young adults in a hematology\/oncology setting. J Pediatr Psychol. 2014;39:1149\u201360.","journal-title":"J Pediatr Psychol"},{"key":"1161_CR38","doi-asserted-by":"publisher","unstructured":"Cheung YT, Liu W, Brinkman TM, Srivastava D, Leisenring WM, Howell RM, Ullrich NJ, Lommel KM, Brouwers P, Gibson, TM, Robison LL, Armstrong GT, Krull KR. Prescription psychoactive medication use in adolescent survivors of childhood cancer and association with adult functional outcomes. JNCI cancer spectrum. 2020;4:pkaa05. https:\/\/doi.org\/10.1093\/jncics\/pkaa057.","DOI":"10.1093\/jncics\/pkaa057"},{"key":"1161_CR39","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/imj.13449","volume":"47","author":"R Pinkerton","year":"2017","unstructured":"Pinkerton R, Hardy JR. Opioid addiction and misuse in adult and adolescent patients with cancer. Intern Med J. 2017;47:632\u20136.","journal-title":"Intern Med J"},{"key":"1161_CR40","doi-asserted-by":"crossref","first-page":"105972","DOI":"10.1016\/j.ypmed.2019.105972","volume":"132","author":"EE Bonar","year":"2020","unstructured":"Bonar EE, Coughlin L, Roche JS, et al. Prescription opioid misuse among adolescents and emerging adults in the United States: A scoping review. Prev Med. 2020;132:105972.","journal-title":"Prev Med."},{"key":"1161_CR41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5055\/jom.2016.0333","volume":"12","author":"KR Peck","year":"2016","unstructured":"Peck KR, Ehrentraut JH, Anghelescu DL. Risk factors for opioid misuse in adolescents and young adults with focus on oncology setting. J Opioid Manag. 2016;12:205\u201316.","journal-title":"J Opioid Manag"},{"key":"1161_CR42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/08897077.2017.1356791","volume":"38","author":"TS Schepis","year":"2017","unstructured":"Schepis TS, Hakes JK. Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically. Subst Abus. 2017;38:407\u201313.","journal-title":"Subst Abus"},{"key":"1161_CR43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/jayao.2019.0047","volume":"8","author":"LC Heathcote","year":"2019","unstructured":"Heathcote LC, Allen JM, Gunn KM, et al. Pain education for adolescents and young adults living beyond cancer: an interdisciplinary meeting report. J Adolesc Young Adult Oncol. 2019;8:529\u201333.","journal-title":"J Adolesc Young Adult Oncol"},{"key":"1161_CR44","first-page":"211","volume":"23","author":"G Nightingale","year":"2017","unstructured":"Nightingale G. The impact of polypharmacy on patient outcomes in older adults with cancer. Cancer J. 2017;23:211\u20138.","journal-title":"Cancer J"},{"key":"1161_CR45","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jgo.2016.07.010","volume":"7","author":"M Sharma","year":"2016","unstructured":"Sharma M, Loh KP, Nightingale G, Mohile SG, Holmes HM. Polypharmacy and potentially inappropriate medication use in geriatric oncology. J Geriatr Oncol. 2016;7:346\u201353.","journal-title":"J Geriatr Oncol"},{"key":"1161_CR46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjopharm.2009.05.002","volume":"7","author":"KL Flood","year":"2009","unstructured":"Flood KL, Carroll MB, Le CV, Brown CJ. Polypharmacy in hospitalized older adult cancer patients: Experience from a prospective, observational study of an oncology-acute care for elders unit. Am J Geriatr Pharmacother. 2009;7:151\u20138.","journal-title":"Am J Geriatr Pharmacother"},{"key":"1161_CR47","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1002\/cncr.27537","volume":"118","author":"AC Kirchhoff","year":"2012","unstructured":"Kirchhoff AC, Lyles CR, Fluchel M, Wright J, Leisenring W. Limitations in health care access and utilization among long-term survivors of adolescent and young adult cancer. Cancer. 2012;118:5964\u201372.","journal-title":"Cancer"},{"key":"1161_CR48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/jayao.2014.0041","volume":"4","author":"HM Parsons","year":"2015","unstructured":"Parsons HM, Harlan LC, Schmidt S, et al. Who treats adolescents and young adults with cancer? A report from the AYA HOPE Study. J Adolesc Young Adult Oncol. 2015;4:141\u201350.","journal-title":"J Adolesc Young Adult Oncol"},{"key":"1161_CR49","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1634\/theoncologist.2015-0492","volume":"21","author":"AM Whitman","year":"2016","unstructured":"Whitman AM, DeGregory KA, Morris AL, Ramsdale EE. A comprehensive look at polypharmacy and medication screening tools for the older cancer patient. Oncologist. 2016;21:723\u201330.","journal-title":"Oncologist"},{"issue":"5","key":"1161_CR50","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1200\/JOP.2016.018317","volume":"13","author":"GS Calip","year":"2017","unstructured":"Calip GS, Xing S, Jun DH, et al. Polypharmacy and adherence to adjuvant endocrine therapy for breast cancer. J Oncol Pract. 2017;13(5):e451\u201362.","journal-title":"J Oncol Pract"},{"key":"1161_CR51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5034\/inquiryjrnl_48.03.04","volume":"48","author":"SC Hill","year":"2011","unstructured":"Hill SC, Zuvekas SH, Zodet MW. Implications of the accuracy of MEPS prescription drug data for health services research. Inquiry. 2011;48:242\u201359.","journal-title":"Inquiry"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-021-01161-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-021-01161-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-021-01161-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T10:10:00Z","timestamp":1710929400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-021-01161-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1007\/s11764-021-01161-0","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received an exemption from the Institutional Review Board at the University of Texas Health Science Center (#HSC-SPH-20\u20130207), as all data used in the study are publicly available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"C.C.M. reports consulting for Freenome. A.C.B, L.A.S., B.A.B., M.A., and C.M. have no disclosures.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}